Abstract:Abstract Activation of the NLRP3 inflammasome involves hierarchical activation and assembly of upstream protein complexes which can lead to a Gasdermin-D (GSDMD) dependent form of lytic cell death coined pyroptosis. Upon cleavage by Caspase-1, GSDMD oligomerizes in the plasma membrane to form pores which act as a conduit for IL-1β release – a potent proinflammatory cytokine that is implicated in a variety of physiological and pathological responses. Prior studies have utilized macrophages as a model system for interrogating the NLRP3 inflammasome, and recent studies with mast cell (MC) extrapolate these macrophage mechanisms to MCs. However, the mechanisms underlying IL-1β secretion in MCs have yet to be interrogated. We are characterizing the detailed mechanisms underlying NLRP3 activation in MCs, with a focus on GSDM-family members in the pathways of IL-1β release. Our data using primary murine MCs indicate that IL-1β is released independently of GSDMD. This correlates with low GSDMD expression in contrast to high expression of GSDME. Thus, our current studies focus on defining roles for GSDME or other mechanisms of IL-1β release from MCs. Notably, our studies demonstrate a critical role for IL-33 priming vs. LPS in the signal 1 priming of MCs for NLRP3 signaling. Taken together we demonstrate that the MC NLRP3 inflammasome signaling and IL-1β release utilize mechanisms distinct from those in macrophages. Supported by grants from NIH (P01-AI141350)

Double DAMPs – NLRP3 priming of murine bone marrow derived mast cells with IL-33 leads to robust IL-1β secretion in a Gasdermin-D independent manner